Soroceanu L - Search Results

1

Glioma migration can be blocked by nontoxic inhibitors of myosin II.

Gillespie GY, Soroceanu L, Manning TJ Jr, Gladson CL, Rosenfeld SS. Gillespie GY, et al. Among authors: soroceanu l. Cancer Res. 1999 May 1;59(9):2076-82. Cancer Res. 1999. PMID: 10232591

2

Modulation of glioma cell migration and invasion using Cl(-) and K(+) ion channel blockers.

Soroceanu L, Manning TJ Jr, Sontheimer H. Soroceanu L, et al. J Neurosci. 1999 Jul 15;19(14):5942-54. doi: 10.1523/JNEUROSCI.19-14-05942.1999. J Neurosci. 1999. PMID: 10407033 Free PMC article.

3

Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma.

Chambers R, Gillespie GY, Soroceanu L, Andreansky S, Chatterjee S, Chou J, Roizman B, Whitley RJ. Chambers R, et al. Among authors: soroceanu l. Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1411-5. doi: 10.1073/pnas.92.5.1411. Proc Natl Acad Sci U S A. 1995. PMID: 7877992 Free PMC article.

4

Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors.

Andreansky S, Soroceanu L, Flotte ER, Chou J, Markert JM, Gillespie GY, Roizman B, Whitley RJ. Andreansky S, et al. Among authors: soroceanu l. Cancer Res. 1997 Apr 15;57(8):1502-9. Cancer Res. 1997. PMID: 9108452

5

Reduced expression of connexin-43 and functional gap junction coupling in human gliomas.

Soroceanu L, Manning TJ Jr, Sontheimer H. Soroceanu L, et al. Glia. 2001 Feb;33(2):107-17. doi: 10.1002/1098-1136(200102)33:2<107::aid-glia1010>3.0.co;2-4. Glia. 2001. PMID: 11180508

6

Loss of vascular endothelial growth factor in human alopecia hair follicles.

Goldman CK, Tsai JC, Soroceanu L, Gillespie GY. Goldman CK, et al. Among authors: soroceanu l. J Invest Dermatol. 1995 May;104(5 Suppl):18S-20S. doi: 10.1038/jid.1995.40. J Invest Dermatol. 1995. PMID: 7738377 Free article. No abstract available.

7

The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors.

Andreansky SS, He B, Gillespie GY, Soroceanu L, Markert J, Chou J, Roizman B, Whitley RJ. Andreansky SS, et al. Among authors: soroceanu l. Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11313-8. doi: 10.1073/pnas.93.21.11313. Proc Natl Acad Sci U S A. 1996. PMID: 8876132 Free PMC article. Review.

8

Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate.

Goldman CK, Kendall RL, Cabrera G, Soroceanu L, Heike Y, Gillespie GY, Siegal GP, Mao X, Bett AJ, Huckle WR, Thomas KA, Curiel DT. Goldman CK, et al. Among authors: soroceanu l. Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8795-800. doi: 10.1073/pnas.95.15.8795. Proc Natl Acad Sci U S A. 1998. PMID: 9671758 Free PMC article.

9

In vitro and in vivo gene delivery mediated by a synthetic polycationic amino polymer.

Goldman CK, Soroceanu L, Smith N, Gillespie GY, Shaw W, Burgess S, Bilbao G, Curiel DT. Goldman CK, et al. Among authors: soroceanu l. Nat Biotechnol. 1997 May;15(5):462-6. doi: 10.1038/nbt0597-462. Nat Biotechnol. 1997. PMID: 9131627

10

Use of chlorotoxin for targeting of primary brain tumors.

Soroceanu L, Gillespie Y, Khazaeli MB, Sontheimer H. Soroceanu L, et al. Cancer Res. 1998 Nov 1;58(21):4871-9. Cancer Res. 1998. PMID: 9809993

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters